MACROGENICS, INC. - Common Stock, par value $0.01 per share (DYNT)

CUSIP: 268157500

Q2 2023 13F Holders as of 30 Jun 2023

Holder snapshot 6 signals
Share change
-40,519
SEC-reported price per share
$0.75
Number of holders
14
Value change
-$57,133
Number of buys
4
Number of sells
5
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
63,551,797

Security key

268157500

Report period

Q2 2023

Institutions

14

Top holders

10

Ownership snapshot

Top reported holders of DYNT - MACROGENICS, INC. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Bellevue Group AG
Disclosed value leader
Bellevue Group AG
Comparable rows
15/15
Latest evidence
31 Mar 2023
13F Lead comparable stake: 15% Showing 1-6 of 15 holder rows.

Quick read

Bellevue Group AG leads the comparable SEC ownership view at 15%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Bellevue Group AG's linked filing trail.
Comparable ownership Top 5
Bellevue Group AG 15%
ARMISTICE CAPITAL, LLC 9.4%
T. Rowe Price Investment Manageme... 4.6%
MILLENNIUM MANAGEMENT LLC 3.1%
Frazier Life Sciences Management,... 2.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Bellevue Group AG
13F
Company
13F
15%
$68,903,077
9,609,913 shares
31 Mar 2023
ARMISTICE CAPITAL, LLC
13F
Company
13F
9.4%
$42,733,200
5,960,000 shares
31 Mar 2023
T. Rowe Price Investment Management, Inc.
13F
Company
13F
4.6%
$20,890,000
2,913,405 shares
31 Mar 2023
MILLENNIUM MANAGEMENT LLC
13F
Company
13F
3.1%
$14,013,000
1,954,350 shares
31 Mar 2023
Frazier Life Sciences Management, L.P.
13F
Company
13F
2.7%
$12,211,973
1,703,204 shares
31 Mar 2023
Assenagon Asset Management S.A.
13F
Company
13F
2.4%
$10,701,311
1,492,512 shares
31 Mar 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
14
Shares
198,646
Rows available
14
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
14
Q2 2023 holders
14
Holder diff
0
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 value Q2 2023 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .